Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Tilray’s (TLRY) subsidiary, Aphria, has launched a new medical cannabis product
  • Aphria made oral strips available to patients for quick relief using THC and CBD-rich varieties
  • Each Aphria medical strip contains micronized cannabinoids that absorb directly into the bloodstream, providing patients with fast-acting relief from a range of conditions
  • Tilray’s (TLRY) shares are up by 0.25 per cent and are trading at $11.90 per share as of 1:29 PM EST

Tilray (TLRY) makes medical cannabis oral strips powered by QuickStrip™ technology available to patients.

Tilray is a cannabis research, production, and distribution organization, whose subsidiary, Aphria, launched a new oral strip with THC and CBD-rich varieties.

Using Aphria’s QuickStrip™ technology, the strips are thin, edible, and dissolve micronized cannabinoids that quickly absorb into the bloodstream for fast relief.

Tilray’s Chairman and CEO, Irwin D. Simon, said,

“[…] Aphria [is] relentlessly committed to investing in patient wellness through a portfolio of new innovative product offerings. […] We look forward to extending our leadership in medical cannabis and to delivering value for patients and shareholders alike.”

President at Tilray Canada, Blair MacNeil, added,

“At Aphria Medical, our goal is to be the trusted partner for patients by providing them with high-quality, precise, and efficacious medical cannabis treatment.”

Tilray’s (TLRY) shares are up by 0.25 per cent and are trading at $11.90 per share as of 1:29 PM EST.

More From The Market Herald

" BioHarvest (CSE:BHSC) predicts 2022 revenue to grow up to 3.5 times

BioHarvest Sciences Inc. (BHSC) expects strong revenue growth to continue in 2022 due to a successful over-delivery of projected revenue targets from last year.

" Icanic Brands (CSE:ICAN) agrees to acquire cannabis extraction company

Icanic Brands Company (ICAN) has signed a definitive agreement to acquire 100 per cent of LEEF Holdings Inc.
Tilray - Denise Faltischek, Head of International and Chief Strategy Officer.

" Tilray (TSX:TLRY) expands Australian medical cannabis offering

Tilray (TLRY) has expanded its medical cannabis product suite in Australia.

" Craftport Cannabis (CSE:CFT) announces $3M private placement

Craftport Cannabis (CFT) has announced a non-brokered private placement for gross proceeds of $3 million.